Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

62
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
62
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

69
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
69
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

42
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
42
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

34
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
34

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Validation of NICVD-NQ Score for Predicting Short-Term Outcomes After Primary PCI.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Clinical Outcomes of the Prospective Pakistan Registry of Echocardiographic Screening in Asymptomatic Pregnant Women.

JACC. Advances·2026
Same author

Reply: RIVAWAR Trial Commentary: Rivaroxaban vs Warfarin in Acute Left Ventricular Thrombus Following Myocardial Infarction.

JACC. Advances·2025
Same author

Point-of-care ultrasound vs. routine transthoracic echocardiography for screening of cardiovascular disease in pregnant women.

European heart journal. Imaging methods and practice·2025
Same author

Twice-Daily Clopidogrel vs Ticagrelor to Reduce Short-Term Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention: The TADCLOT Trial.

Journal of the American College of Cardiology·2025
Same author

Prognosticating short-term outcomes in patients with STEMI-ACS and intra-procedural slow-flow/no-reflow phenomenon.

Herz·2025

Related Experiment Video

Updated: Sep 20, 2025

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

28.1K

Left Ventricular Functional Remodeling after Primary Percutaneous Coronary Intervention.

Mahesh Kumar Batra1, Muhammad Atif Malik2, Kamran Ahmed Khan1

  • 1Department of Cardiology, National Institute of Cardiovascular Diseases, Karachi, Pakistan.

Journal of Cardiovascular Echography
|June 7, 2022
PubMed
Summary

Primary percutaneous coronary intervention (PCI) significantly improves left ventricular (LV) ejection fraction and dimensions in patients with acute myocardial infarction (AMI). This revascularization strategy enhances LV function and reduces adverse remodeling within six months post-procedure.

Keywords:
Left ventricular ejection fractionleft ventricular end-diastolic dimensionleft ventricular end-systolic dimensionprimary percutaneous coronary interventionwall motion score index

More Related Videos

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.7K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.6K

Related Experiment Videos

Last Updated: Sep 20, 2025

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

28.1K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.7K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.6K

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Echocardiography

Background:

  • Left ventricular (LV) function post-revascularization is crucial for acute myocardial infarction (AMI) prognosis.
  • Limited data exist on LV function changes after revascularization in specific populations.
  • Primary percutaneous coronary intervention (PCI) is a key reperfusion strategy for AMI.

Purpose of the Study:

  • To evaluate changes in LV function and dimensions after primary PCI.
  • To assess echocardiographic parameters at 3 and 6 months post-intervention.
  • To understand LV remodeling following primary PCI in AMI patients.

Main Methods:

  • 188 patients undergoing primary PCI for AMI were included.
  • Exclusion criteria: pre-existing LV dysfunction, prior PCI, congenital heart disease.
  • Echocardiography assessed LV ejection fraction (LVEF), LV end-diastolic dimension (LVEDD), and wall motion score index (WMSI) at baseline, 3, and 6 months.

Main Results:

  • Significant improvement in LVEF from baseline (39.79 ± 6.2%) at 3 months (+5.11%) and 6 months (+6.38%) (P < 0.001).
  • Reduction in LVEDD from baseline (46.23 ± 3.86 mm) to 44.68 ± 2.81 mm at 6 months.
  • Decrease in wall motion score index (WMSI) observed at 3 and 6 months post-PCI.

Conclusions:

  • Primary PCI effectively preserves and improves LV systolic function in AMI patients.
  • Revascularization via primary PCI contributes to favorable LV remodeling.
  • The findings support primary PCI as a beneficial treatment for maintaining LV function post-AMI.